Загрузка...
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
Cetuximab is a chimeric monoclonal antibody that targets the epidermal growth factor receptor. The role of cetuximab is paramount in several subsets of head and neck cancer. In particular, the EXTREME study has indicated cetuximab as the only drug to improve survival when associated with cisplatin a...
Сохранить в:
| Главные авторы: | , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Dove Medical Press
2009
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2886337/ https://ncbi.nlm.nih.gov/pubmed/20616911 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|